Bulagsac, Dulcesima B.
HRN: 05-10-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/23/2023
04/29/2023
IV
1.5g
Q6H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes